Publication Name	World Journal of Clinical Cases
Manuscript ID	79070
Country	China

Received	2022-08-01 01:39
Peer-Review Started	2022-08-01 01:40
To Make the First Decision
Return for Revision	2022-09-05 08:49
Revised	2022-09-19 12:29
Second Decision	2022-11-10 03:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-11-10 08:31
Articles in Press	2022-11-10 08:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-11-15 01:15
Publish the Manuscript Online	2022-12-14 07:20

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Evidence Review
Article Title	Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Xiao-Fei Zhang, Pei-Yi Liu, Shu-Juan Zhang, Kuai-Le Zhao and Wei-Xin Zhao
ORCID	Author(s) ORCID Number Kuai-Le Zhao http://orcid.org/0000-0001-8663-2874 Wei-Xin Zhao http://orcid.org/0000-0002-6448-8848
Funding Agency and Grant Number	Funding Agency Grant Number Key Clinical Specialty Project of Shanghai
Corresponding Author	Wei-Xin Zhao, MD, N/A, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, No. 270 Dongan Road, Xuhui, Shanghai 200032, China. zwx_zhxf@163.com
Key Words	Esophageal squamous cell carcinoma; Radical radiotherapy and chemotherapy; Involving field irradiation; Chemoradiotherapy; Radical treatment
Core Tip	For the radical treatment of esophageal squamous cell carcinoma, the effect of radiotherapy and chemotherapy is equivalent to that of surgery. In the era of immunization, it is recommended to use involved field irradiation. Fluorouracil plus cisplatin regimen is the standard chemotherapy regimen, FOLFOX regimen and paclitaxel plus fluorouracil regimen are optional concurrent chemotherapy regimens. The toxic and side effects of different chemotherapy regimens are very different, which can be selected according to the actual situation of patients.
Publish Date	2022-12-14 07:20
Citation	Zhang XF, Liu PY, Zhang SJ, Zhao KL, Zhao WX. Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma. World J Clin Cases 2022; 10(35): 12804-12811
URL	https://www.wjgnet.com/2307-8960/full/v10/i35/12804.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i35.12804

Full Article (PDF)	WJCC-10-12804.pdf
Full Article (Word)	WJCC-10-12804.docx
Manuscript File	79070_Auto_Edited-JLW.docx
Answering Reviewers	79070-Answering reviewers.pdf
Audio Core Tip	79070-Audio core tip.wav
Conflict-of-Interest Disclosure Form	79070-Conflict-of-interest statement.pdf
Copyright License Agreement	79070-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	79070-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	79070-Language certificate.pdf
Peer-review Report	79070-Peer-review(s).pdf
Scientific Misconduct Check	79070-Bing-Gao CC-2.png
Scientific Editor Work List	79070-Scientific editor work list.pdf